(a) Accrediting body means an entity approved by the Federal Substance Abuse Mental Health Services Administration (SAMHSA) to accredit all programs pursuant to 42 CFR parts 8.1 through 8.6 using opioid full agonist treatment medications.

(b) Active treatment is the period from pre-admission through discharge.

(c) Admission assessment is a face-to-face pre-admission service between a prospective patient and clinical staff for the purpose of determining a preliminary diagnosis, appropriateness for service, initial plan of treatment, including identifying problem areas to be addressed in the treatment/recovery plan, and the type and level of services needed by the patient.

(d) Ancillary withdrawal is a service whereby patients in mild to moderate or persistent withdrawal receive symptom relief and/or addiction medications after an assessment of the level of withdrawal determined by the use of a standardized assessment instrument. Providers must receive office approved designation to provide this service.

(e) Approved medications means any medication approved for opioid treatment by Federal authorities and any medication appropriate for the treatment of substance use disorder.

(f) Brief intervention is a face-to-face pre-admission service between a prospective patient and clinical staff when screening results indicate at risk behavior. The brief intervention educates patients about their substance use, alerts them to possible consequences, and is intended to encourage healthier choices.

(g) Brief treatment is a face-to-face service between an active patient and clinical staff and must include a target behavior and an evidence-based or clinical practice upon which the treatment is based. Brief treatment may be used throughout the course of treatment to meet specific goals, motivate patients or support medicated supported recovery.

(h) Central registry system means the central registry established and maintained by the office pursuant to section 19.16 of the Mental Hygiene Law.

(i) Collateral person is a member of a patient’s family or household, significant others, or persons who are directly affected by regular interaction with the patient, or who have the capability to affect both the patient’s chemical dependence and recovery.

(j) Collateral visit is a face-to-face service between a clinical staff member and a collateral person for the purpose of providing an intervention in the service of the primary patient’s progress in treatment.

(k) Complex care coordination is a service provided to or on behalf of a patient when a critical event occurs or the patient’s condition requires significant coordination with other service providers. Complex care coordination is distinguished from routine case coordination and must occur within five working days of another service.

(l) Continuing care treatment is a treatment protocol that offers clinical support for the ongoing disease management needs of patients. Patients have completed the goals of active treatment or an opioid full agonist taper and are admitted to continuing care.

(m) Group counseling is a face-to-face service between one or more clinical staff and multiple patients at the same time, to be delivered consistent with patient treatment/recovery plans, their development or emergent issues. Group counseling sessions must be structured in size and duration to maximize therapeutic benefit for each participant. Program policies must include a process for determining group size, group purpose, monitoring patient experience, and assessing group efficacy.

(n) Individual counseling is a face-to-face service between a clinical staff member and a patient focused on the needs of the patient to be delivered consistent with the treatment/recovery plan, its development or emergent issues.

(o) Initial services or pre-admission services are services prior to admission as the first step in developing a treatment/recovery plan, focusing on issues that need to be addressed to ensure successful engagement and admission into treatment and any other urgent or emergent issues. Initial/pre-admission services address priority goals based on presenting problem(s) identified during the patient’s assessment and provide focus for the critical period of treatment engagement. Services which may be delivered preadmission will be identified by the office.

(p) Intensive outpatient services (IOS) is an outpatient treatment service provided by a team of clinical staff for patients who require a time-limited, multi-faceted array of services, structure, and support to achieve and sustain recovery. Programs that offer intensive outpatient treatment must make available individual and group counseling, family counseling when appropriate, relapse prevention and coping skills training, motivational enhancement, and drug refusal skills training.

(q) Medication administration and observation is face-to-face administration or dispensing of a medication by medical staff, to be delivered in conjunction with observation of the patient prior to the administration and after, as appropriate to the medication and patient’s condition.

(r) Medication assisted treatment (MAT) means treatment of chemical dependence i.e., substance use disorder and concomitant conditions with medications requiring a prescription or order from an authorized prescribing professional.

(s) Medication management is a face-to-face service with a prescribing professional for one of the following purposes:

(t) Naloxone emergency overdose prevention kit means a kit as prescribed pursuant to State law.

(u) Opioid medical maintenance is a designated office-based opioid treatment (OBOT) program limited to patients who meet specific criteria as described in section 822.16(g) of this Part.

(v) Opioid taper means a medical treatment protocol that, after a period of stabilization, utilizes approved medications in gradually decreasing doses to the point of zero milligrams (no dose) followed by continuing care treatment as described in this Part, or discharge.

(w) Patient is an individual including a significant other who meets with clinical and/or peer staff for the purpose of assessment or treatment. Active patient means a patient who is admitted to a program and has an active treatment plan.

(x) Patient centered is a collaborative care approach to individualized treatment resulting in a treatment/recovery plan that is respectful of the patient’s needs and choices. It is guided by patients and produced in partnership with care providers for treatment and recovery. It supports patient preferences and a recovery orientation.

(y) Peer support service is a face-to-face service provided by a peer advocate as defined in Part 800 of this Title. Peer support services are services for the purpose of outreach for engaging an individual to consider entering treatment, reinforcing current patients’ engagement in treatment, and connecting patients to community-based recovery supports consistent with treatment/recovery and discharge plans.

(z) Pre-admission services include services to prospective clients, including family members or significant others, provided in order to engage, assess and stabilize immediate needs. They may include peer support, brief intervention, assessment, medication management, and individual counseling.

(aa) Screening is a face-to-face pre-admission service with a clinical staff member for the purpose of identifying patients who have problems with substance use. Screening results must be shared by the clinical staff in an individual face-to-face session.

(ab) Specialized opioid service are those not defined in this Part and are generally research-oriented in nature. Such specialized services shall be reviewed and approved by the office prior to implementation and operation in accordance with office policy, procedures, and requirements.

(ac) Substance use disorder outpatient rehabilitation services (outpatient rehabilitation services) are services offered by programs which have been certified to provide outpatient rehabilitation services; such services are designed to assist individuals with more chronic conditions as further defined in this Part who are typically scheduled to attend the outpatient rehabilitation program three to five days per week for at least two hours per day.

(ad) Substance use disorder outpatient program is an office certified program which provides outpatient services that assist individuals with a substance use disorder and their family members and/or significant others and may also provide outpatient rehabilitation services and/or intensive outpatient services (IOS); and sites where addiction medications are administered to treat opioid use disorder, as well as other SUDs following one or more medical treatment protocols as defined in this Part. This term encompasses medical and comprehensive support services including counseling, educational and vocational rehabilitation. The term also includes the Narcotic Treatment Program (NTP) as defined by the Federal Drug Enforcement Agency (DEA) in 21 CFR section 1301. An NTP or Opioid Treatment Program (OTP) requires Federal and State approval.

(ae) Transfer is an intra-program function (i.e., between outpatient and outpatient rehabilitation within the same provider or between different PRUs of the same provider); and may also be an inter-program function (i.e., between two different providers).

(af) Treatment/recovery plan is the plan developed by clinical staff with the patient and based on the admission assessment and initial services.

(ag) Visit means one or more services provided to a patient and/or collateral person on a single day.